California State Teachers Retirement System (CalSTRS)’s Actuate Therapeutics ACTU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-585
Closed -$3.58K 3063
2025
Q4
$3.58K Buy
585
+217
+59% +$1.49K ﹤0.01% 2992
2025
Q3
$2.46K Buy
368
+1
+0.3% +$7 ﹤0.01% 3029
2025
Q2
$2.24K Buy
+367
New +$3.21K ﹤0.01% 2950

Other funds holding ACTU

California State Teachers Retirement System (CalSTRS)'s ACTU Position: Q1 2026 in Review

California State Teachers Retirement System (CalSTRS) sold out of Actuate Therapeutics (ACTU) in Q1 2026, closing a stake of 585 shares — an estimated $3.58K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in ACTU in Q2 2025 and held it in 3 quarters. The position peaked at $3.58K in Q4 2025. 61 funds tracked by Wall St. Rank hold ACTU as of Q1 2026.

  • California State Teachers Retirement System (CalSTRS) reported no remaining Actuate Therapeutics position as of Q1 2026 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 585 Actuate Therapeutics shares in Q1 2026, an estimated $3.58K.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Actuate Therapeutics in Q2 2025 and held it in 3 quarters.
  • California State Teachers Retirement System (CalSTRS)'s Actuate Therapeutics position peaked at $3.58K in Q4 2025.
  • 61 funds tracked by Wall St. Rank held Actuate Therapeutics as of Q1 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q1 2026, filed 18 May 2026.